Season 2 - Episode 4 - What to Listen For Friday at the FDA Webcast

S2 E4 – What to Listen For Friday at the FDA Webcast

Manal Abdelmalek joins the Surfers to share expectations in advance of Friday's FDA Webcast on NASH Drug Development

FDA’s Friday webcast titled “Regulatory Perspectives for Development of Drugs for Treatment of NASH” is the agency’s long-awaited public event to provide better definition on what trial must achieve for a NASH drug to gain approval. In advance of that event, Stephen, Louise, Manal and Roger share expectations for that session. Kitty Yale, Chief Development Officer for Akero Therapeutics and a participant in our post-session podcast, sends in four points to explore. Whether you care about the process of drug development or simply the results in terms of drug approvals, you will find this episode a thought-provoking prequel to the actual event.

[PDF] FDA current thinking on NASH studies 2021

How useful was this post?

Click on a star to rate it!

Average rating / 5. Vote count:

No votes so far! Be the first to rate this post.

Request A Transcript of This Episode
Request Transcript

Join The Discussion…

Ask Our Panelists A Question…

Podcast Quesitonaire
Is your question directed towards one of our panelists?

If your question is answered in our next Podcast, would you like be tagged?

Join The Discussion!

Subscribe to our free emails. Receive access to our Discussion Group. Ask your questions directly to our "Surfers"